XNAS
OFLX
Market cap264mUSD
Oct 08, Last price
26.25USD
1D
-0.27%
1Q
-12.00%
Jan 2017
-52.92%
IPO
112.90%
Name
Omega Flex Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Omega Flex, Inc. and its affiliated companies operate as an international manufacturer and distributor of flexible metal hosing and related accessories, catering to markets across North America and beyond. Their product portfolio includes versatile gas piping, complete with necessary fittings, engineered for installation in both residential and commercial properties. Additionally, they produce specialized corrugated medical tubing, which finds application in various healthcare environments such as hospitals, outpatient clinics, dental and veterinary practices, and research laboratories. These offerings are marketed under several recognized brand names, including TracPipe, CounterStrike, AutoSnap, AutoFlare, DoubleTrac, DEF-Trac, and MediTrac. Omega Flex serves a broad spectrum of industries, encompassing construction, manufacturing, transportation, petrochemical, and pharmaceutical sectors. The company employs a multi-channel distribution strategy, engaging independent sales representatives, authorized distributors, original equipment manufacturers (OEMs), direct sales teams, and its official website to reach customers. Established in 1975, the company was initially known as Tofle America, Inc. before officially changing its name to Omega Flex, Inc. in 1996. Its corporate headquarters are situated in Exton, Pennsylvania.
Key people
Kevin Hoben
Executive Chairman of the Board · since 2024
Edwin Moran
President, Director · since 2024
Dean Rivest
Chief Executive Officer, Director · since 2024
Independent Vice Chairman of the Board · since 2018
Matthew Unger
Chief Financial Officer, Vice President - Finance · since 2022
Susan Asch
Vice President, General Counsel, Company Secretary · since 2024
Lead Independent Director · since 2019
Independent Director · since 2019
David Evans
Independent Director · since 1996
Stephen Shea
Independent Director · since 2024
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||